These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 1980236)

  • 1. Alpha-adrenergic blockers: mechanism of action, blood pressure control, and effects of lipoprotein metabolism.
    Nash DT
    Clin Cardiol; 1990 Nov; 13(11):764-72. PubMed ID: 1980236
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic changes during antihypertensive therapies.
    Krone W; Nägele H
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():69-73; discussion 74. PubMed ID: 2575177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of effects on lipid metabolism of antihypertensive drugs with alpha- and beta-adrenergic antagonist properties.
    Leren P
    Am J Med; 1987 Jan; 82(1A):31-5. PubMed ID: 2879461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of calcium antagonists and adrenergic antihypertensive drugs on plasma lipids and cellular cholesterol metabolism.
    Krone W; Müller-Wieland D; Nägele H; Behnke B; Greten H
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S199-202. PubMed ID: 2455133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review of the effects of doxazosin, a new selective alpha 1-adrenergic inhibitor, on lipoproteins in patients with essential hypertension.
    Pool JL; Taylor AA; Nelson EB
    Am J Med; 1989 Aug; 87(2A):57S-61S. PubMed ID: 2569825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antihypertensive therapy and lipid metabolism].
    Krone W; Müller-Wieland D; Greten H
    Klin Wochenschr; 1984 Mar; 62(5):193-202. PubMed ID: 6143851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment.
    Rabkin SW
    J Clin Pharmacol; 1993 Mar; 33(3):286-91. PubMed ID: 8096525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alpha 1-adrenoreceptor blockade and the molecular basis of lipid metabolism alterations.
    Pool JL; Lenz ML; Taylor AA
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():23-33. PubMed ID: 1979819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma lipid lowering effects of doxazosin, a new selective alpha1 adrenergic inhibitor for systemic hypertension.
    Pool JL
    Am J Cardiol; 1987 May; 59(14):46G-50G. PubMed ID: 2884853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alpha 1-blockade for the treatment of hypertension: a megastudy of terazosin in 2214 clinical practice settings.
    Itskovitz HD
    Clin Ther; 1994; 16(3):490-504. PubMed ID: 7923316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adrenoreceptor antagonists and agonists on clearance of emulsion models of triacylglycerol-rich lipoproteins from plasma in rats.
    Mackintosh VS; Elsegood CL; Redgrave TG
    Clin Exp Pharmacol Physiol; 1991 Nov; 18(11):775-88. PubMed ID: 1685947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum lipoproteins during treatment with antihypertensive drugs.
    Weidmann P; de Courten M; Ferrari P; Böhlen L
    J Cardiovasc Pharmacol; 1993; 22 Suppl 6():S98-105. PubMed ID: 7508069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alpha-1-adrenergic blockade and lipoprotein metabolism in essential hypertension.
    Ferrier C; Beretta-Piccoli C; Weidmann P; Mordasini R
    Clin Pharmacol Ther; 1986 Nov; 40(5):525-30. PubMed ID: 2876796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of alpha- and beta-blocker antihypertensive therapy on blood lipids: a multicenter trial.
    Goto Y
    Am J Med; 1984 Feb; 76(2A):72-8. PubMed ID: 6142645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of alpha-adrenergic and beta-adrenergic receptor blockade on lipid metabolism.
    Ferrara LA; Marotta T; Rubba P; De Simone B; Leccia G; Soro S; Mancini M
    Am J Med; 1986 Feb; 80(2A):104-8. PubMed ID: 2868656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of alpha- and beta-adrenergic antagonists on plasma apolipoproteins and forearm blood flow in patients with mild hypertension.
    Sacks FM; Creager MA; Gallagher SJ; Loscalzo J; Dzau VJ
    Am J Med; 1989 Jan; 86(1B):8-13. PubMed ID: 2563311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihypertensive drugs and blood lipids: the Oslo study.
    Leren P; Eide I; Foss OP; Helgeland A; Hjermann I; Holme I; Kjeldsen SE; Lund-Larsen PG
    J Cardiovasc Pharmacol; 1982; 4 Suppl 2():S222-4. PubMed ID: 6177960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of antihypertensive and lipid actions of terazosin and atenolol in essential hypertension.
    Silke B; Guy S; Humphreys JE
    J Hum Hypertens; 1992 Jun; 6(3):221-5. PubMed ID: 1352828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of doxazosin on lipids, lipoprotein lipases, and cholesterol synthesis in the golden hamster.
    Jansen H; Lammers R; Baggen MG; Birkenhäger JC
    J Cardiovasc Pharmacol; 1989; 13 Suppl 2():S5-9; discussion S9-10. PubMed ID: 2471016
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD; Henderson AD; Wadsworth J; Poulter C; Gelding S; Richmond W; Sever PS; Elkeles RS
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.